Aspire Biopharma is developing next generation absorption of medicine that will have a significant impact on the opioid crisis. Our nano technology drug formulation directly targets pain and inflammation bypassing the gastrointestinal tract.
Aspire’s technology comes from a new mechanism of action (absorption pathway) which allows for instant absorption in the mouth. Benefits of “instant absorption” are to provide nearly instant treatment impact and also allows high dose absorption.
Our technology can be applied to any number of proven, approved, “do no harm” drugs and supplements, such as analgesics, erectile disfunction and traumatic brain injury drugs.
Company Details
- Founded
- -
- Address
- 370 Harbor Drive, Suite 250,puerto Rico
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.aspirebiolabs.com
- HQ
- Humacao, Puerto Rico
Aspire Biopharma Inc. Questions
Aspire Biopharma Inc.'s website is http://www.aspirebiolabs.com
Aspire Biopharma Inc.'s LinkedIn profile is https://pr.linkedin.com/company/aspire-biopharma
Aspire Biopharma Inc.'s industry is
Biotechnology Research
Aspire Biopharma Inc.'s top competitors are
Mgo Leisure Wear,
Basel Medical Group,
Cycurion,
Mgo Global Inc.,
Anthony, Linder & Cacomanolis, Pllc,
The Good Clinic,
Aethlon Medical, Inc.,
Spac Feed,
Aspire Biosciences,
Nextnrg - Powering What’s Next.
Aspire Biopharma Inc.'s categories are Biotechnology Research
Aspire Biopharma Inc.'s founding year is 2019
